7.46
price down icon0.67%   -0.05
after-market After Hours: 7.46
loading
Avadel Pharmaceuticals Plc stock is traded at $7.46, with a volume of 972.19K. It is down -0.67% in the last 24 hours and down -5.69% over the past month. Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
See More
Previous Close:
$7.51
Open:
$7.42
24h Volume:
972.19K
Relative Volume:
0.75
Market Cap:
$720.86M
Revenue:
$47.56M
Net Income/Loss:
$-156.83M
P/E Ratio:
-4.0765
EPS:
-1.83
Net Cash Flow:
$-127.98M
1W Performance:
-8.69%
1M Performance:
-5.69%
6M Performance:
-42.88%
1Y Performance:
-54.54%
1-Day Range:
Value
$7.31
$7.59
1-Week Range:
Value
$7.31
$8.305
52-Week Range:
Value
$7.31
$19.09

Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile

Name
Name
Avadel Pharmaceuticals Plc
Name
Phone
636-449-1830
Name
Address
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Name
Employee
188
Name
Twitter
@AvadelPharma
Name
Next Earnings Date
2025-03-03
Name
Latest SEC Filings
Name
AVDL's Discussions on Twitter

Compare AVDL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
AVDL
Avadel Pharmaceuticals Plc
7.46 720.86M 47.56M -156.83M -127.98M -1.83
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
163.50 72.50B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.98 47.08B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.16 45.99B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.29 17.52B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
312.26 13.78B 2.76B 1.11B 898.10M 22.77

Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-11-25 Initiated Deutsche Bank Buy
Jun-12-24 Initiated Rodman & Renshaw Buy
Mar-05-24 Reiterated H.C. Wainwright Buy
Mar-05-24 Reiterated Needham Buy
Mar-05-24 Reiterated Oppenheimer Outperform
Feb-06-24 Initiated UBS Buy
Nov-30-22 Upgrade Jefferies Hold → Buy
Aug-10-22 Downgrade Jefferies Buy → Hold
Jul-28-22 Resumed Craig Hallum Buy
May-26-22 Downgrade Stifel Buy → Hold
Sep-23-21 Initiated Needham Buy
Jul-31-20 Initiated Oppenheimer Outperform
Jul-21-20 Initiated SVB Leerink Outperform
Jun-30-20 Initiated H.C. Wainwright Buy
Apr-03-20 Initiated Jefferies Buy
Mar-12-20 Initiated Stifel Buy
Feb-26-20 Initiated Piper Sandler Overweight
Jan-30-20 Initiated Craig Hallum Buy
Jun-14-19 Upgrade Ladenburg Thalmann Neutral → Buy
Feb-08-19 Downgrade Ladenburg Thalmann Buy → Neutral
View All

Avadel Pharmaceuticals Plc Stock (AVDL) Latest News

pulisher
03:49 AM

Teacher Retirement System of Texas Increases Stock Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World

03:49 AM
pulisher
Apr 01, 2025

Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference - The Manila Times

Apr 01, 2025
pulisher
Mar 29, 2025

When (AVDL) Moves Investors should Listen - news.stocktradersdaily.com

Mar 29, 2025
pulisher
Mar 29, 2025

Charles Schwab Investment Management Inc. Raises Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World

Mar 29, 2025
pulisher
Mar 29, 2025

Swiss National Bank Increases Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World

Mar 29, 2025
pulisher
Mar 25, 2025

Avadel Pharmaceuticals Announces Publication of Manuscripts on Narcolepsy Management in CNS Drugs Supplement - Nasdaq

Mar 25, 2025
pulisher
Mar 25, 2025

Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians - The Manila Times

Mar 25, 2025
pulisher
Mar 25, 2025

Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with - EIN News

Mar 25, 2025
pulisher
Mar 18, 2025

Atria Investments Inc Has $281,000 Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Avadel Pharmaceuticals at UBS Virtual CNS Day: Strategic Growth Insights By Investing.com - Investing.com UK

Mar 17, 2025
pulisher
Mar 17, 2025

Bullish Avadel Pharmaceuticals Insiders Loaded Up On US$761.7k Of Stock - simplywall.st

Mar 17, 2025
pulisher
Mar 16, 2025

Arizona State Retirement System Acquires 2,938 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World

Mar 16, 2025
pulisher
Mar 12, 2025

Avadel Pharmaceuticals at Leerink Conference: Strategic Growth Plans By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

Insider Trading At Avadel Pharmaceuticals plc (NASDAQ: AVDL): What Did We Note? - Stocks Register

Mar 12, 2025
pulisher
Mar 12, 2025

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Average Rating of “Buy” from Analysts - Defense World

Mar 12, 2025
pulisher
Mar 10, 2025

Analyzing Avadel Pharmaceuticals plc (AVDL) After Recent Trading Activity - Knox Daily

Mar 10, 2025
pulisher
Mar 08, 2025

HC Wainwright Issues Pessimistic Outlook for AVDL Earnings - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Avadel Pharmaceuticals Announces Executive Equity Grants By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 07, 2025

Avadel Pharmaceuticals Announces Executive Equity Grants - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Avadel Pharmaceuticals Plc to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Avadel Pharmaceuticals PLC Sponsored ADR to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

What is HC Wainwright’s Forecast for AVDL Q3 Earnings? - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

What is Lifesci Capital’s Forecast for AVDL Q2 Earnings? - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Oppenheimer & Co. Inc. Boosts Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - MarketBeat

Mar 06, 2025
pulisher
Mar 06, 2025

Sanctuary Advisors LLC Takes Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Rhumbline Advisers Increases Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

What is Lifesci Capital’s Estimate for AVDL Q1 Earnings? - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences - The Manila Times

Mar 05, 2025
pulisher
Mar 05, 2025

New York State Common Retirement Fund Sells 389,555 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Avadel Pharmaceuticals (NASDAQ:AVDL) Given “Buy” Rating at HC Wainwright - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2024 Earnings Call Transcript - MSN

Mar 04, 2025
pulisher
Mar 04, 2025

Deutsche Bank Adjusts Avadel Pharmaceuticals Price Target to $13 From $12, Maintains Buy Rating - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Avadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from Needham & Company LLC - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada

Mar 04, 2025
pulisher
Mar 03, 2025

Avadel Pharmaceuticals Reports Strong Growth in 2024 - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Oppenheimer maintains Avadel Outperform rating, $22 target By Investing.com - Investing.com UK

Mar 03, 2025
pulisher
Mar 03, 2025

Earnings call transcript: Avadel Pharmaceuticals Q4 2024 reveals revenue miss - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

Avadel Pharma earnings missed by $0.03, revenue fell short of estimates - Investing.com Australia

Mar 03, 2025
pulisher
Mar 03, 2025

Avadel Pharmaceuticals PLC reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 03, 2025
pulisher
Mar 03, 2025

AVADEL PHARMACEUTICALS PLC SEC 10-K Report - TradingView

Mar 03, 2025
pulisher
Mar 03, 2025

Avadel: Q4 Earnings Snapshot - CTPost

Mar 03, 2025
pulisher
Mar 03, 2025

Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

Avadel Pharmaceuticals Reiterates 2025 Guidance -March 03, 2025 at 07:16 am EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 01, 2025

Is Avadel Pharmaceuticals plc (AVDL) the Best Small Cap Pharma Stocks to Buy Now? - Insider Monkey

Mar 01, 2025
pulisher
Mar 01, 2025

Avadel Pharmaceuticals (AVDL) Expected to Announce Earnings on Monday - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Avadel Pharmaceuticals PLC expected to post a loss of 4 cents a shareEarnings Preview - TradingView

Feb 28, 2025
pulisher
Feb 25, 2025

Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3 - The Manila Times

Feb 25, 2025

Avadel Pharmaceuticals Plc Stock (AVDL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$10.77
price up icon 4.06%
$32.65
price up icon 0.37%
$97.42
price down icon 0.52%
$8.66
price up icon 0.70%
$108.31
price up icon 1.22%
$312.26
price up icon 1.75%
Cap:     |  Volume (24h):